Stocks Health care OBX
NASDAQ · Health careObsidian Therapeutics, Inc. (OBX)
At June 30, 2026 it held $0 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about Obsidian Therapeutics, Inc.
- Net worth
- Obsidian Therapeutics, Inc. has a market value (market cap) of $848.8M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What Obsidian Therapeutics, Inc. does
Obsidian Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OBX.
Earnings: every quarter and the next report date
Latest SEC filings
What Obsidian Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 5, 2026Passive stake (5% or more) SCHEDULE 13G
- August 28, 2026IPO registration S-1
- August 14, 2026Exhibits 8-K/A
- August 14, 2026
- August 11, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 3, 2026
- August 3, 2026
Insider trades
What the people running Obsidian Therapeutics, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns OBX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| RA Capital Management, L.P.13G, passive with 3 related filers | 9.7% | August 10, 2026 |
| Paradigm BioCapital Advisors LP13G, passive with 3 related filers | 6.6% | October 5, 2026 |
| Deep Track Capital, LP13G, passive with 3 related filers | 5.37% | August 11, 2026 |
| Novo Holdings A/S13G, passive | 5.1% | August 10, 2026 |
Largest institutional holders
Insiders
Questions about OBX
What does Obsidian Therapeutics, Inc. do?
Obsidian Therapeutics, Inc. is a company in the Health care sector, listed on NASDAQ as OBX. Its shares trade on NASDAQ under the ticker OBX.
What is Obsidian Therapeutics, Inc.'s net worth?
Obsidian Therapeutics, Inc. has a market value (market cap) of $848.8M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
When did Obsidian Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from October 5, 2026.
Similar companies
Compare OBX with
Follow OBX
Get an email when Obsidian Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Obsidian Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.